Monthly Archives: January 2009
The doctors didn’t expect Don Harrington to survive the 1954 car accident that left him a quadriplegic.
Then the medical wisdom of the day said the 19-year-old college sophomore from Plano might live at most another five years.
But those doctors didn’t know Donna Harrington, who cared for her son and defied the odds for the next 50 years. She continued in her labor of love well past her 100th birthday.
Lab rats with spinal cord injuries have been treated with adult stem cells to reverse their paralysis according to a new study.
So-called progenitor stem cells were transplanted from the lining of other rats’ spinal cords into rodents with serious spinal cord injuries for the study, headed by Miodrag Stojkovic, the deputy director and head of the Cellular Reprogramming Laboratory at Centro de Investigacion Principe Felipe in Spain.
Fenelon Falls resident praises support of association
More than six years ago, a single moment changed Matt Hughes’ life forever.
In August 2002, Hughes was involved in a pool accident that left him with a spinal cord injury that paralyzed him from the chest down.
Speaking at his home in Fenelon, Hughes said that he is still making adjustments in his life.
Medical device company NeuroMetrix Inc. has paid $350,000 to buy intellectual property and technology from Foxborough- based neurostimulation device maker Cyberkinetics Neurotechnology Systems Inc. used to treat spinal-cord and peripheral nerve injuries.
Can I serve you now?
FOR the past eight years, America’s government has declined to fund new research into one of the world’s most promising medical technologies: the use of human embryonic stem cells to repair or replace damaged tissue in the diseased and injured. Embryonic stem cells are special for two reasons, one scientific and one ethical. The scientific reason is that they are able to turn into any of the body’s myriad cell types, which is why they might be used in this way.
It was a homecoming to remember as Central welcomed back J. Johnson and honored him as the school’s basketball king on Friday night.
It was Johnson’s second appearance of the week at a Central ballgame after his Jan. 19 release from Saint Francis Hospital in Tulsa. He had been there since suffering a serious spinal cord injury in a Dec. 27 car wreck.
The Central senior said it’s great to be back in Sequoyah County and he enjoyed watching the Tigers play.
SCOTS Formula 1 hero David Coulthard is used to life in the fast lane. And three months after retiring from racing, he’s showing no signs of slowing down.
The 37-year-old became a dad in November, and is fitting in spending time with nine-week-old son Dayton and fiancee Karen Minier with business interests around the world, as well as preparing to become a TV pundit for the BBC’s Formula 1 coverage.
New study found transplantation of stem cells reverses paralysis in laboratory tests
Valencia, Spain – A new study has found that transplantation of stem cells from the lining of the spinal cord, called ependymal stem cells, reverses paralysis associated with spinal cord injuries in laboratory tests. The findings show that the population of these cells after spinal cord injury was many times greater than comparable cells from healthy animal subjects. The results open a new window on spinal cord regenerative strategies. The study is published in the journal Stem Cells.
In 2007, there were over 6 million motor vehicle accidents in the United States, and of those, 2.5 million were injured and more than 41,000 lost their lives. Spine fractures are a significant cause of morbidity and mortality. This research provides evidence that the combination of air bags and seat belts affords the best protection against spinal fractures sustained in motor vehicle crashes.
Stem cell research is making another step to the future in the United States. Geron Corp, a California-based company has won the Food and Drug Administration’s approval to use embryonic cells to heal people suffering from spinal cord injury.
President and chief executive officer of the company, Thomas B. Okarma said the project “is the dawn of a new era in medical therapeutics.” He also added that the FDA’s decision has nothing to do with the change of administration in Washington, even if, unlike former president George W. Bush, Barack Obama has voiced strong support for human embryonic stem cell research.